08/21/2025
3:26 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2025
3:58 PM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2025
3:41 PM | ANI Pharmaceuticals (Issuer)
Pera Antonio R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2025
3:42 PM | ANI Pharmaceuticals (Issuer)
Thoma Jeanne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2025
3:02 PM | ANI Pharmaceuticals (Subject)
Pera Antonio R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2025
4:47 PM | ANI Pharmaceuticals (Subject)
Thoma Jeanne (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/18/2025
3:29 PM | ANI Pharmaceuticals (Issuer)
Gassert Chad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2025
3:32 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2025
3:34 PM | ANI Pharmaceuticals (Issuer)
Walsh Patrick D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2025
4:43 PM | ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2025
4:46 PM | ANI Pharmaceuticals (Issuer)
Gutwerg Ori (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for ANIP and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for ANI Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
08/14/2025
4:48 PM | ANI Pharmaceuticals (Issuer)
Lalwani Nikhil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2025
4:53 PM | ANI Pharmaceuticals (Issuer)
Rowland Thomas Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2025
4:40 PM | ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2025
4:38 PM | ANI Pharmaceuticals (Issuer)
HAUGHEY THOMAS (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2025
5:04 PM | ANI Pharmaceuticals (Subject)
Lalwani Nikhil (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/12/2025
3:15 PM | ANI Pharmaceuticals (Subject)
CAREY STEPHEN P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/08/2025
5:56 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2025
6:01 AM | ANI Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/23/2025
5:53 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/14/2025
3:11 PM | ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2025
3:19 PM | ANI Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/16/2025
4:24 PM | ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
3:00 PM | ANI Pharmaceuticals (Subject)
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
| Form SCHEDULE 13G | |
06/04/2025
6:10 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/27/2025
5:15 PM | ANI Pharmaceuticals (Issuer)
Walsh Patrick D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/27/2025
5:16 PM | ANI Pharmaceuticals (Issuer)
Thoma Jeanne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/27/2025
5:17 PM | ANI Pharmaceuticals (Issuer)
TANNENBAUM RENEE P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/27/2025
5:18 PM | ANI Pharmaceuticals (Issuer)
Pera Antonio R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/27/2025
5:19 PM | ANI Pharmaceuticals (Issuer)
Leonard Matthew J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/27/2025
5:21 PM | ANI Pharmaceuticals (Issuer)
HAUGHEY THOMAS (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
6:00 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2025
7:05 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2025
7:10 PM | ANI Pharmaceuticals (Issuer)
Mutz Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
3:21 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/12/2025
7:50 AM | ANI Pharmaceuticals (Subject)
Shanmugam Muthusamy (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/09/2025
5:55 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2025
5:57 AM | ANI Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/08/2025
8:14 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2025
8:15 AM | ANI Pharmaceuticals (Filer)
| Form DEFA14A | |
04/14/2025
3:17 PM | ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Gold Hit $3,500. Here’s What’s Next… (Ad) Gold just smashed through $3,500—and some experts believe that’s only the beginning. With big banks like Goldman Sachs and JPMorgan forecasting as high as $6,000, now may be the most critical time in a generation to move. Claim Your Copy Before Prices Surge Again |
04/10/2025
3:38 PM | ANI Pharmaceuticals (Filer)
| Form DEF 14A | |
04/10/2025
3:40 PM | ANI Pharmaceuticals (Filer)
| Form DEFA14A | |
04/10/2025
3:42 PM | ANI Pharmaceuticals (Filer)
| Form ARS | |
03/31/2025
3:35 PM | ANI Pharmaceuticals (Filer)
| Form PRE 14A | |
03/25/2025
3:44 PM | ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2025
3:47 PM | ANI Pharmaceuticals (Issuer)
Lalwani Nikhil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
6:00 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/14/2025
4:17 PM | ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2025
4:19 PM | ANI Pharmaceuticals (Issuer)
Gutwerg Ori (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2025
4:20 PM | ANI Pharmaceuticals (Issuer)
Lalwani Nikhil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2025
4:22 PM | ANI Pharmaceuticals (Issuer)
Mutz Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2025
4:28 PM | ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2025
7:50 PM | ANI Pharmaceuticals (Subject)
Meridian Venture Partners II GP, L.P. (Filed by)
| Form SCHEDULE 13D/A | |
03/11/2025
6:00 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/10/2025
7:28 PM | ANI Pharmaceuticals (Issuer)
Davis Krista (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:06 PM | ANI Pharmaceuticals (Issuer)
Davis Krista (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:07 PM | ANI Pharmaceuticals (Issuer)
Gutwerg Ori (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
5:55 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2025
6:05 AM | ANI Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/24/2025
3:33 PM | ANI Pharmaceuticals (Issuer)
Davis Krista (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
7:11 PM | ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
7:12 PM | ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
7:13 PM | ANI Pharmaceuticals (Issuer)
Davis Krista (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
7:14 PM | ANI Pharmaceuticals (Issuer)
Gassert Chad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
7:15 PM | ANI Pharmaceuticals (Issuer)
Gutwerg Ori (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
7:16 PM | ANI Pharmaceuticals (Issuer)
Lalwani Nikhil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
7:17 PM | ANI Pharmaceuticals (Issuer)
Mutz Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
7:19 PM | ANI Pharmaceuticals (Issuer)
Rowland Thomas Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
7:19 PM | ANI Pharmaceuticals (Issuer)
Shanmugam Muthusamy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
6:00 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2025
3:15 PM | ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
6:00 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2024
4:59 PM | ANI Pharmaceuticals (Issuer)
CAREY STEPHEN P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
4:35 PM | ANI Pharmaceuticals (Subject)
CAREY STEPHEN P. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024
3:20 PM | ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
4:08 PM | ANI Pharmaceuticals (Issuer)
Davis Krista (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2024
4:38 PM | ANI Pharmaceuticals (Issuer)
Lalwani Nikhil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/26/2024
6:44 PM | ANI Pharmaceuticals (Subject)
Lalwani Nikhil (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/20/2024
6:00 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
7:01 AM | ANI Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/08/2024
5:55 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2024
4:57 PM | ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
3:50 PM | ANI Pharmaceuticals (Issuer)
Cook Meredith (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
8:13 AM | ANI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/13/2024
3:23 PM | ANI Pharmaceuticals (Issuer)
Davis Krista (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
3:44 PM | ANI Pharmaceuticals (Issuer)
Lalwani Nikhil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
MarketBeat All Access